| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Dianthus Therapeutics, Inc. (DNTH) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. DNTH is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 89.7K | $7.40M | - | |
| Other | 16.2K | $1.33M | - | |
| VP | 8.0K | $659.8K | -26,530 | |
| Dir | 0 | - | - | |
| CEO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 23, 2019 | Gardner Jason | See Remarks | Sell | 2,897 | $15.10 | $43,754.55 | -1.1% | |
| Dec 20, 2019 | Gardner Jason | See Remarks | Sell | 76,711 | $15.16 | $1,162,616.57 | -22.2% | |
| Dec 20, 2019 | Davis John C. Jr | Chief Medical Officer | Sale+OE | 919 | $15.00 | $13,785.00 | -10.0% | |
| Dec 10, 2019 | Gardner Jason | See Remarks | Sell | 4,392 | $15.10 | $66,319.20 | -1.3% | |
| Dec 10, 2019 | Davis John C. Jr | Chief Medical Officer | Sale+OE | 21,669 | $15.00 | $325,035.00 | -56.6% | |
| Dec 2, 2019 | Cooke Michael P. | Chief Scientific Officer | Sell | 7,500 | $13.00 | $97,520.01 | -1.0% | |
| Nov 20, 2019 | Cooke Michael P. | Chief Scientific Officer | Sell | 5,000 | $12.00 | $60,000.00 | -2.0% | |
| Nov 1, 2019 | Cooke Michael P. | Chief Scientific Officer | Sell | 5,000 | $10.67 | $53,333.50 | -1.9% | |
| Oct 1, 2019 | Cooke Michael P. | Chief Scientific Officer | Sell | 5,000 | $10.01 | $50,064.00 | -1.9% | |
| Sep 19, 2019 | Cooke Michael P. | Chief Scientific Officer | Sell | 1,656 | $12.00 | $19,872.00 | -0.6% |